reference/19291612

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/19291612

Outgoing Links

Predicate	Object
contentType	Clinical Trial\|Clinical Trial, Phase II\|Comparative Study\|Journal Article\|Multicenter Study
endingPage	1805
issn	0923-7534
issueIdentifier	11
pageRange	1799-1805
publicationName	Annals of oncology : official journal of the European Society for Medical Oncology
startingPage	1799
bibliographicCitation	Motzer RJ, Rakhit A, Thompson J, Gurney H, Selby P, Figlin R, Negrier S, Ernst S, Siebels M, Ginsberg M, Rittweger K, Hooftman L. Phase II trial of branched peginterferon-alpha 2a (40 kDa) for patients with advanced renal cell carcinoma. Ann Oncol. 2002 Nov;13(11):1799–805. doi: 10.1093/annonc/mdf288. PMID: 12419754.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_dd7614f36a44f0c4094d0ccd6be6049f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a904bd12d1058cce13b5633993a9a6c4 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_af71f3b3d6674ed9ec4a12193cdd5851 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6ec5692eb1e2de16759e78408ac6a617 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a209f55b96fdacdead1a123799e5fd5e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3186dbcaacc2e89547bcb0c39d1f79bc http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c899bc7bd57bd95b18088135bda0a732 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fa6299504cfbbaa59f4d4facac69d06a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_57125db20a9c9da35ab7a9f1020e0a54 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a03eca6acd5ad35a16aae162b8fb593e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_872d8e17b6338270ed919c0f51d883d6 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5f3bab140d73d60bee4c257b72fe589a
date	200211
identifier	https://pubmed.ncbi.nlm.nih.gov/12419754 https://doi.org/10.1093/annonc/mdf288
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/1846 https://portal.issn.org/resource/ISSN/0923-7534
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Phase II trial of branched peginterferon-alpha 2a (40 kDa) for patients with advanced renal cell carcinoma
discusses	http://id.nlm.nih.gov/mesh/M0029376 http://id.nlm.nih.gov/mesh/M0025711 http://id.nlm.nih.gov/mesh/M0552528 http://id.nlm.nih.gov/mesh/M0018641 http://id.nlm.nih.gov/mesh/M0023207
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D009361Q000473 http://id.nlm.nih.gov/mesh/D016898Q000008 http://id.nlm.nih.gov/mesh/D016898Q000493 http://id.nlm.nih.gov/mesh/D002292Q000188 http://id.nlm.nih.gov/mesh/D007680Q000097 http://id.nlm.nih.gov/mesh/D007680Q000188 http://id.nlm.nih.gov/mesh/D002292Q000097
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D009367 http://id.nlm.nih.gov/mesh/D019798Q000097 http://id.nlm.nih.gov/mesh/D000077190 http://id.nlm.nih.gov/mesh/D004305 http://id.nlm.nih.gov/mesh/D009392Q000379 http://id.nlm.nih.gov/mesh/D011994 http://id.nlm.nih.gov/mesh/D007279 http://id.nlm.nih.gov/mesh/D015996 http://id.nlm.nih.gov/mesh/D007680Q000601 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D016898Q000633 http://id.nlm.nih.gov/mesh/D006207 http://id.nlm.nih.gov/mesh/D016896 http://id.nlm.nih.gov/mesh/D015088Q000097 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D001707 http://id.nlm.nih.gov/mesh/D002292Q000601 http://id.nlm.nih.gov/mesh/D007677 http://id.nlm.nih.gov/mesh/D002292Q000401 http://id.nlm.nih.gov/mesh/D007680Q000473 http://id.nlm.nih.gov/mesh/D004334 http://id.nlm.nih.gov/mesh/D002292Q000473 http://id.nlm.nih.gov/mesh/D018570 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D005500 http://id.nlm.nih.gov/mesh/D007680Q000401 http://id.nlm.nih.gov/mesh/D000368 http://id.nlm.nih.gov/mesh/D001682 http://id.nlm.nih.gov/mesh/D008875
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7706 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8661 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6983 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9614 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8593 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11449 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_7d6a1edc08997e3d7b61d7a07051efb5 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7170 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_850d3dd3f0465864f03b25f855d284d1

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127537750

Total number of triples: 80.